Hospital-Free cancer treatment? outpatient CAR-T therapy shows promise
NCT ID NCT05459571
Summary
This study tested a personalized immune cell therapy (called axicabtagene ciloleucel or CAR-T) given alongside preventive steroids to people with aggressive large B-cell lymphoma that had returned or not responded to prior treatments. The main goal was to see if giving this powerful therapy in an outpatient clinic, instead of requiring a hospital stay, was safe and effective. Researchers closely monitored 35 participants for severe side effects and how well the cancer responded.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Duarte, California, 91010, United States
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Henry-Joyce Cancer Clinic
Nashville, Tennessee, 37232, United States
-
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, 84112, United States
-
Intermountain Healthcare
Murray, Utah, 84107, United States
-
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Methodist Healthcare System of San Antonio
San Antonio, Texas, 78229, United States
-
Oncology Hematology Care Clinical Trials, LLC
Cincinnati, Ohio, 45242, United States
-
Prisma Health - Upstate
Greenville, South Carolina, 29615, United States
-
Tennessee Oncology, PLLC
Nashville, Tennessee, 37203, United States
-
UCLA
Los Angeles, California, 90025, United States
-
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, 21201, United States
-
University of Virginia Health System
Charlottesville, Virginia, 22908, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23219, United States
-
Virginia Oncology Associates
Norfolk, Virginia, 23502, United States
Conditions
Explore the condition pages connected to this study.